CytoSorbents Corp. (CTSO)
0.36
0.00 (0.00%)
USD |
NASDAQ |
Aug 26, 16:00
0.36
0.00 (0.00%)
After-Hours: 20:00
CytoSorbents Total Liabilities (Quarterly) : 38.71M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.71M |
| March 31, 2026 | 38.37M |
| December 31, 2025 | 41.74M |
| September 30, 2025 | 36.73M |
| June 30, 2025 | 36.40M |
| March 31, 2025 | 36.24M |
| December 31, 2024 | 39.85M |
| September 30, 2024 | 34.80M |
| June 30, 2024 | 36.69M |
| March 31, 2024 | 28.14M |
| December 31, 2023 | 33.18M |
| September 30, 2023 | 29.06M |
| June 30, 2023 | 28.35M |
| March 31, 2023 | 28.51M |
| December 31, 2022 | 27.86M |
| September 30, 2022 | 23.13M |
| June 30, 2022 | 23.65M |
| March 31, 2022 | 27.84M |
| December 31, 2021 | 26.94M |
| September 30, 2021 | 24.46M |
| June 30, 2021 | 23.81M |
| March 31, 2021 | 10.22M |
| December 31, 2020 | 10.73M |
| September 30, 2020 | 24.05M |
| June 30, 2020 | 24.94M |
| Date | Value |
|---|---|
| March 31, 2020 | 22.91M |
| December 31, 2019 | 23.96M |
| September 30, 2019 | 21.95M |
| June 30, 2019 | 16.94M |
| March 31, 2019 | 15.98M |
| December 31, 2018 | 15.81M |
| September 30, 2018 | 14.18M |
| June 30, 2018 | 13.38M |
| March 31, 2018 | 13.86M |
| December 31, 2017 | 13.84M |
| September 30, 2017 | 12.74M |
| June 30, 2017 | 14.17M |
| March 31, 2017 | 9.860M |
| December 31, 2016 | 8.356M |
| September 30, 2016 | 9.479M |
| June 30, 2016 | 8.814M |
| March 31, 2016 | 3.248M |
| December 31, 2015 | 3.044M |
| September 30, 2015 | 3.447M |
| June 30, 2015 | 2.528M |
| March 31, 2015 | 6.198M |
| December 31, 2014 | 4.505M |
| September 30, 2014 | 1.549M |
| June 30, 2014 | 2.769M |
| March 31, 2014 | 3.299M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Abbott Laboratories | 57.45B |
| AngioDynamics, Inc. | 96.34M |
| Alphatec Holdings, Inc. | 779.49M |
| AtriCure, Inc. | 160.21M |
| Baxter International, Inc. | 13.61B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 37.96M |
| Shareholders Equity (Quarterly) | -0.751M |
| Debt to Equity Ratio | -39.93 |
| Current Ratio | 0.6551 |
| Net Debt Paydown Yield | -2.34% |